Pharvaris said it plans to initiate a Phase 3 clinical trial by the end of the year to test…
Articles by Andrea Lobo
NTLA-2002, the investigational gene-editing therapy from Intellia Therapeutics, reduced the number of monthly swelling attacks by a mean of…
The risk of venous thromboembolism (VTE), which occurs when a blood clot forms in a vein and obstructs blood flow,…
The case of a man with a rare form of hereditary angioedema (HAE) where the levels of the C1-inhibitor…
Most people with hereditary angioedema (HAE) can usually predict an impending swelling attack based on early, or prodromal, signs…
An 83-year-old woman suddenly developed angioedema of the airway as a result of neck trauma while being treated with…
Mutations in the CPN1 gene leading to a deficiency in the activity of the carboxypeptidase N (CPN) enzyme were found…
A 60-year-old man with hereditary angioedema (HAE) caused by an unknown mutation developed visual loss due to swelling of…
Long-term preventive treatment with Haegarda reduced the number and severity of attacks and the use of rescue medications in…
Long-term prophylaxis, or preventive treatment, with Orladeyo (berotralstat) is well tolerated, and results in sustained reductions in swelling attacks…